Soon after FDA warned the manufacturer involved in a massive nationwide recall of valsartan- and losartan-containing drugs, the recall is expanding. Find out why.
While President Donald Trump pushed drugmakers to lower prices in 2018—and some complied—many are starting out this year with price hikes.
Fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the aorta, FDA said in a new warning.
A new non-small cell lung cancer (NSCLC) treatment is available to healthcare providers immediately.
After an expanded recall of the blood pressure medication valsartan, FDA is warning the manufacturer of the carcinogenic ingredient involved.
Two major drug recalls in the last week include an expanded recall of a widely used blood pressure medication as well as over-the-counter infant ibuprofen.
Find out how healthcare organizations and analysts feel about new Medicare Part D proposals and drug pricing.
FDA approved the first biosimilar to rituximab (Rituxan, Genentech) to treat non-Hodgkin lymphoma.
Here are the top 2 novel cancer drugs cleared by the agency.
FDA approved an autoinjector to treat rheumatoid arthritis and other diseases.